Skip to content
Recall Observatory FDA recall evidence

Drug product

NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Each ML contains: 0.288% Sodium Phosphate Monobasic USP, 0.42% Sodium Phosphate Dibasic USP, 5% Mannitol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155, Orlando, FL 32835 NDC: 73198-0083-00

D-0719-2022

March 08, 2022

Class II

Product summary

Firm
Olympia Compounding Pharmacy dba Olympia Pharmacy
Event
Event 89717
Status
Terminated
Classification
Class II
Quantity
2634 vials
Official record key
drug-enforcement:D-0719-2022

Official wording

Reason: Product found to be Sub Potent or Exceeded reconstitution time

Code information: Lot: D24005 Exp. 4/5/22; C41008 Exp. 3/8/22

Distribution pattern: Nationwide in the USA including Puerto Rico.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Product found to be Sub Potent or Exceeded reconstitution time